title: Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
authors.affiliation: Rush Cancer Institute, Rush Presbyterian St. Luke's Medical Center, Chicago, IL, USA.
authors.forename: P
authors.initials: P
authors.lastname: Venugopal
authors.forename: S
authors.initials: S
authors.lastname: Manson
authors.forename: H D
authors.initials: HD
authors.lastname: Preisler
mesh_terms: D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016913:Blood Component Transfusion; D019496:Cancer Vaccines / Q000627:therapeutic use; D019090:Case Management; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D016503:Drug Delivery Systems; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D010166:Palliative Care; D012008:Recurrence; D012074:Remission Induction
chemical_list: D019496:Cancer Vaccines